{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:55:26Z","timestamp":1793048126612,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["CA17112"],"award-info":[{"award-number":["CA17112"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020624","name":"NIHR Nottingham Biomedical Research Centre","doi-asserted-by":"publisher","award":["IS-BRC-1215-20003"],"award-info":[{"award-number":["IS-BRC-1215-20003"]}],"id":[{"id":"10.13039\/501100020624","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020098","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006662","name":"National Institute on Handicapped Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006662","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013322","name":"European Federation of Pharmaceutical Industries and Associations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ebiom.2026.106229","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T08:00:31Z","timestamp":1774339231000},"page":"106229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Usefulness of plasma bile acid profile as a prognostic biomarker for drug-induced liver injury"],"prefix":"10.1016","volume":"126","author":[{"given":"Maria J.","family":"Monte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi Dong-Binh","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9950-7201","authenticated-orcid":false,"given":"Jane I.","family":"Grove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingzhou","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9586-4896","authenticated-orcid":false,"given":"M. Isabel","family":"Lucena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1565-0757","authenticated-orcid":false,"given":"Ra\u00fal J.","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7077-8078","authenticated-orcid":false,"given":"Sabine","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Gerbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Einar S.","family":"Bjornsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Stirnimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helgi K.","family":"Bjornsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann K.","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashi K.","family":"Ramaiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara A.","family":"Paciga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Lingaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7341-9174","authenticated-orcid":false,"given":"Edmond","family":"Atallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Robles-Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1955-6060","authenticated-orcid":false,"given":"Sophia L.","family":"Samodelov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Poetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Ramage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Fowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.H.","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew E.","family":"Cramp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janisha","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Elsharkawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose J.G.","family":"Marin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd A.","family":"Kullak-Ublick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3924-4830","authenticated-orcid":false,"given":"Guruprasad P.","family":"Aithal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ebiom.2026.106229_bib1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.livres.2021.07.002","article-title":"Bile acid receptors and signaling crosstalk in the liver, gut and brain","volume":"5","author":"Ferrell","year":"2021","journal-title":"Liver Res"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106229_bib2","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1152\/physrev.00027.2002","article-title":"Bile salt transporters: molecular characterization, function, and regulation","volume":"83","author":"Trauner","year":"2003","journal-title":"Physiol Rev"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106229_bib3","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.2741\/3399","article-title":"The enterohepatic circulation of bile acids in mammals: form and functions","volume":"14","author":"Hofmann","year":"2009","journal-title":"Front Biosci"},{"issue":"2\u20133","key":"10.1016\/j.ebiom.2026.106229_bib4","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.mam.2012.10.009","article-title":"The SLCO (former SLC21) superfamily of transporters","volume":"34","author":"Hagenbuch","year":"2013","journal-title":"Mol Asp Med"},{"key":"10.1016\/j.ebiom.2026.106229_bib5","series-title":"The Liver Biology and Pathobiology","first-page":"1050","article-title":"Drug interactions in the liver","author":"Aithal","year":"2020"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106229_bib6","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/s41591-020-1023-0","article-title":"Polygenic architecture informs potential vulnerability to drug-induced liver injury","volume":"26","author":"Koido","year":"2020","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106229_bib7","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1080\/13547500500399979","article-title":"Increased serum bile acids as a possible biomarker of hepatotoxicity in Brazilian workers exposed to solvents in car repainting shops","volume":"10","author":"Nunes de Paiva","year":"2005","journal-title":"Biomarkers"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106229_bib8","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/toxsci\/kfu195","article-title":"Glycodeoxycholic acid levels as prognostic biomarker in acetaminophen-induced acute liver failure patients","volume":"142","author":"Woolbright","year":"2014","journal-title":"Toxicol Sci"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106229_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193824","article-title":"Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans","volume":"13","author":"Luo","year":"2018","journal-title":"PloS One"},{"issue":"31","key":"10.1016\/j.ebiom.2026.106229_bib10","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000016717","article-title":"Serum metabolome and targeted bile acid profiling reveals potential novel biomarkers for drug-induced liver injury","volume":"98","author":"Ma","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106229_bib11","doi-asserted-by":"crossref","first-page":"852","DOI":"10.3390\/metabo11120852","article-title":"Targeted metabolomics analysis of bile acids in patients with idiosyncratic drug-induced liver injury","volume":"11","author":"Xie","year":"2021","journal-title":"Metabolites"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106229_bib12","first-page":"619","article-title":"Integrated analysis of serum and fecal metabolites reveals the role of bile acid metabolism in drug-induced liver injury: implications for diagnostic and prognostic biomarkers","volume":"13","author":"Yu","year":"2025","journal-title":"J Clin Transl Hepatol"},{"issue":"41","key":"10.1016\/j.ebiom.2026.106229_bib13","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000027464","article-title":"Use of bile acids as potential markers of liver dysfunction in humans: a systematic review","volume":"100","author":"Azer","year":"2021","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106229_bib14","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1080\/17425255.2021.1999410","article-title":"Biomarkers of idiosyncratic drug-induced liver injury (DILI) - a systematic review","volume":"17","author":"Atallah","year":"2021","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106229_bib15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-019-0105-0","article-title":"Drug-induced liver injury","volume":"5","author":"Andrade","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106229_bib16","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/hep.29802","article-title":"Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: an international collaborative effort","volume":"69","author":"Church","year":"2019","journal-title":"Hepatol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106229_bib17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s41512-023-00155-z","article-title":"Study design for development of novel safety biomarkers of drug-induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case\u2013control study","volume":"7","author":"Grove","year":"2023","journal-title":"Diagn Progn Res"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106229_bib18","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/clpt.2011.58","article-title":"Case definition and phenotype standardization in drug-induced liver injury","volume":"89","author":"Aithal","year":"2011","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106229_bib19","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","article-title":"EASL Clinical Practice Guidelines: Drug-induced liver injury","volume":"70","year":"2019","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106229_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167166","article-title":"New insights into the regulation of bile acids synthesis during the early stages of liver regeneration: a human and experimental study","volume":"1870","author":"Uriarte","year":"2024","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106229_bib21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jchromb.2007.09.031","article-title":"High-performance liquid chromatography-tandem mass spectrometry for the analysis of bile acid profiles in serum of women with intrahepatic cholestasis of pregnancy","volume":"860","author":"Ye","year":"2007","journal-title":"J Chromatogr B Analytl Technol Biomedical Life Sci"},{"key":"10.1016\/j.ebiom.2026.106229_bib22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s41512-019-0064-7","article-title":"A simple, step-by-step guide to interpreting decision curve analysis","volume":"3","author":"Vickers","year":"2019","journal-title":"Diagn Progn Res"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106229_bib23","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3390\/cimb46020078","article-title":"Gut-Liver Axis as a therapeutic target for drug-induced liver injury","volume":"46","author":"Tao","year":"2024","journal-title":"Curr Issues Mol Biol"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106229_bib24","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4254\/wjh.v13.i4.433","article-title":"Bile acid indices as biomarkers for liver diseases I: diagnostic markers","volume":"13","author":"Alamoudi","year":"2021","journal-title":"World J Hepatol"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106229_bib25","doi-asserted-by":"crossref","first-page":"G685","DOI":"10.1152\/ajpgi.00207.2004","article-title":"Cytokine regulation of human sterol 12alpha-hydroxylase (CYP8B1) gene","volume":"288","author":"Jahan","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.ebiom.2026.106229_bib26","article-title":"Alteration of bile acids and omega-6 PUFAs are correlated with the progression and prognosis of drug-induced liver injury","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106229_bib27","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/cpt.1222","article-title":"Can bile salt export pump inhibition testing in drug discovery and development reduce liver injury risk? An international transporter consortium perspective","volume":"104","author":"Kenna","year":"2018","journal-title":"Clinl Pharmacol Ther"},{"issue":"14","key":"10.1016\/j.ebiom.2026.106229_bib28","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3748\/wjg.15.1677","article-title":"Bile-acid-induced cell injury and protection","volume":"15","author":"Perez","year":"2009","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106229_bib29","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1136\/gutjnl-2016-313369","article-title":"Drug-induced liver injury: recent advances in diagnosis and risk assessment","volume":"66","author":"Kullak-Ublick","year":"2017","journal-title":"Gut"},{"issue":"45","key":"10.1016\/j.ebiom.2026.106229_bib30","doi-asserted-by":"crossref","first-page":"41690","DOI":"10.1074\/jbc.M105117200","article-title":"Transcriptional regulation of the human sterol 12alpha-hydroxylase gene (CYP8B1): roles of heaptocyte nuclear factor 4alpha in mediating bile acid repression","volume":"276","author":"Zhang","year":"2001","journal-title":"J Biol Chem"},{"issue":"10174","key":"10.1016\/j.ebiom.2026.106229_bib31","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0140-6736(18)31877-4","article-title":"Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses","volume":"393","author":"Ovadia","year":"2019","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106229_bib32","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S2468-1253(22)00093-0","article-title":"Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial","volume":"7","author":"Thompson","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106229_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/rcm.9731","article-title":"Perturbations in human bile acid profiles following drug-induced liver injury investigated using semitargeted high-resolution mass spectrometry","volume":"38","author":"Mireault","year":"2024","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106229_bib34","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1124\/dmd.111.040758","article-title":"In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans","volume":"40","author":"Dawson","year":"2012","journal-title":"Drug Metab Dispos"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106229_bib35","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1111\/liv.12193","article-title":"Role of chemical structures and the 1331T>C bile salt export pump polymorphism in idiosyncratic drug-induced liver injury","volume":"33","author":"Ulzurrun","year":"2013","journal-title":"Liver Int"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106229_bib36","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1007\/s00204-021-03114-z","article-title":"Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes","volume":"95","author":"Quint\u00e1s","year":"2021","journal-title":"Arch Toxicol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106229_bib37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/toxsci\/kfab003","article-title":"Evaluating the sensitivity and specificity of promising circulating biomarkers to diagnose liver injury in humans","volume":"181","author":"Llewellyn","year":"2021","journal-title":"Toxicol Sci"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106229_bib38","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/s41467-023-36858-6","article-title":"Tandem mass tag-based quantitative proteomic profiling identifies candidate serum biomarkers of drug-induced liver injury in humans","volume":"14","author":"Ravindra","year":"2023","journal-title":"Nat Commun"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426001118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426001118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T20:01:59Z","timestamp":1783972919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396426001118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":38,"alternative-id":["S2352396426001118"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106229","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Usefulness of plasma bile acid profile as a prognostic biomarker for drug-induced liver injury","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106229","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106229"}}